Items Tagged ‘amgen’

July 27, 2018

Mayo Clinic in the News Weekly Highlights for July 27, 2018

By Emily Blahnik

STAT, Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline, buoying hopes for treatment by Damian Garde — The Phase 2 trial, which employed multiple statistical measures, failed its primary goal. Four doses of BAN2401 didn’t outperform placebo, and the high dose was tested on just 161 patients. Furthermore, the metric Biogen and Eisai used to […]

View full entry

Tags: alzheimer's disease, amgen, anesthesia, Big Blue Dragon Boat Race, bioethics, brain freeze, BRCA gene, Cancer, dementia, Dr. Amaal Starling, Dr. Amit Sood, Dr. Asad Javed.


February 9, 2012

FDA panel votes against Xgeva for prostate cancer

By

panel of cancer experts voted against a new use for Amgen’s Xgeva in prostate cancer on Wednesday, saying the drug’s ability to slow the spread of the disease did not translate into meaningful benefits for patients.The Food and Drug Administration’s cancer drug panel voted 12-1 that the benefits of the drug did not outweigh its […]

View full entry

Tags: amgen, cancer drug panel, Dr. Ronald Richardson, FDA, Food and Drug Administration, prostate cancer, Xgeva


Contact Us · Privacy Policy